144 related articles for article (PubMed ID: 10865186)
21. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
Bhavnani BR; Berco M; Binkley J
J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
23. Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
Berco M; Bhavnani BR
J Soc Gynecol Investig; 2001; 8(4):245-54. PubMed ID: 11525901
[TBL] [Abstract][Full Text] [Related]
24. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
25. Estrogen levels do not correlate with improvement in cognition.
Thal LJ; Thomas RG; Mulnard R; Sano M; Grundman M; Schneider L
Arch Neurol; 2003 Feb; 60(2):209-12. PubMed ID: 12580705
[TBL] [Abstract][Full Text] [Related]
26. Premarin-induced increases in coronary and uterine blood flow in nonpregnant sheep.
Clark KE; Baker RS; Lang U
Am J Obstet Gynecol; 2000 Jul; 183(1):12-7. PubMed ID: 10920301
[TBL] [Abstract][Full Text] [Related]
27. Gene expression analyses of vitellogenin, choriogenin and estrogen receptor subtypes in the livers of male medaka (Oryzias latipes) exposed to equine estrogens.
Ishibashi H; Uchida M; Koyanagi A; Kagami Y; Kusano T; Nakao A; Yamamoto R; Ichikawa N; Tominaga N; Ishibashi Y; Arizono K
J Appl Toxicol; 2016 Nov; 36(11):1392-400. PubMed ID: 26863931
[TBL] [Abstract][Full Text] [Related]
28. The analysis of estrone and 17beta-estradiol by stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry: application to urine samples after oral administration of conjugated equine estrogens.
Stopforth A; Burger BV; Crouch AM; Sandra P
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):156-64. PubMed ID: 17581803
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site.
Harrison LL; Harari D
J Clin Pharmacol; 2002 Oct; 42(10):1134-41. PubMed ID: 12362928
[TBL] [Abstract][Full Text] [Related]
30. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
31. A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat.
Washburn SA; Adams MR; Clarkson TB; Adelman SJ
Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):251-4; discussion 254-6. PubMed ID: 8395768
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Englund DE; Johansson ED
Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein.
Wilcox JG; Hwang J; Hodis HN; Sevanian A; Stanczyk FZ; Lobo RA
Fertil Steril; 1997 Jan; 67(1):57-62. PubMed ID: 8986684
[TBL] [Abstract][Full Text] [Related]
34. Biologic effects of delta-8-estrone sulfate in postmenopausal women.
Bhavnani BR; Cecutti A; Dey MS
J Soc Gynecol Investig; 1998; 5(3):156-60. PubMed ID: 9614646
[TBL] [Abstract][Full Text] [Related]
35. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.
Rahn DD; Good MM; Roshanravan SM; Shi H; Schaffer JI; Singh RJ; Word RA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3728-36. PubMed ID: 24947034
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
Schug BS; Donath F; Blume HH
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
[TBL] [Abstract][Full Text] [Related]
37. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: experimental results.
Rohr UD; Saeger-Lorenz K
J Pharm Sci; 2002 Mar; 91(3):810-21. PubMed ID: 11920767
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
[TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
